Literature DB >> 29384148

Paediatrics: Addressing the health burden of childhood cancer survivors - improvements are needed.

Tara O Henderson1, Kevin C Oeffinger2.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29384148     DOI: 10.1038/nrclinonc.2017.187

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  9 in total

1.  Childhood cancer survivors, late effects, and a new model for understanding survivorship.

Authors:  Kevin C Oeffinger; Leslie L Robison
Journal:  JAMA       Date:  2007-06-27       Impact factor: 56.272

2.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  Circulation       Date:  2013-06-05       Impact factor: 29.690

3.  Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association.

Authors:  Steven E Lipshultz; M Jacob Adams; Steven D Colan; Louis S Constine; Eugene H Herman; Daphne T Hsu; Melissa M Hudson; Leontien C Kremer; David C Landy; Tracie L Miller; Kevin C Oeffinger; David N Rosenthal; Craig A Sable; Stephen E Sallan; Gautam K Singh; Julia Steinberger; Thomas R Cochran; James D Wilkinson
Journal:  Circulation       Date:  2013-09-30       Impact factor: 29.690

4.  Exercise and risk of major cardiovascular events in adult survivors of childhood hodgkin lymphoma: a report from the childhood cancer survivor study.

Authors:  Lee W Jones; Qi Liu; Gregory T Armstrong; Kirsten K Ness; Yutaka Yasui; Katie Devine; Emily Tonorezos; Luisa Soares-Miranda; Charles A Sklar; Pamela S Douglas; Leslie L Robison; Kevin C Oeffinger
Journal:  J Clin Oncol       Date:  2014-10-13       Impact factor: 44.544

5.  General internists' preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey.

Authors:  Eugene Suh; Christopher K Daugherty; Kristen Wroblewski; Hannah Lee; Mackenzie L Kigin; Kenneth A Rasinski; Jennifer S Ford; Emily S Tonorezos; Paul C Nathan; Kevin C Oeffinger; Tara O Henderson
Journal:  Ann Intern Med       Date:  2014-01-07       Impact factor: 25.391

6.  Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors.

Authors:  Aileen B Chen; Rinaa S Punglia; Karen M Kuntz; Peter M Mauch; Andrea K Ng
Journal:  J Clin Oncol       Date:  2009-09-14       Impact factor: 44.544

7.  Individual prediction of heart failure among childhood cancer survivors.

Authors:  Eric J Chow; Yan Chen; Leontien C Kremer; Norman E Breslow; Melissa M Hudson; Gregory T Armstrong; William L Border; Elizabeth A M Feijen; Daniel M Green; Lillian R Meacham; Kathleen A Meeske; Daniel A Mulrooney; Kirsten K Ness; Kevin C Oeffinger; Charles A Sklar; Marilyn Stovall; Helena J van der Pal; Rita E Weathers; Leslie L Robison; Yutaka Yasui
Journal:  J Clin Oncol       Date:  2014-10-06       Impact factor: 44.544

Review 8.  Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort.

Authors:  Paul C Nathan; Jennifer S Ford; Tara O Henderson; Melissa M Hudson; Karen M Emmons; Jacqueline N Casillas; E Anne Lown; Kirsten K Ness; Kevin C Oeffinger
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544

9.  The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE).

Authors:  Nickhill Bhakta; Qi Liu; Kirsten K Ness; Malek Baassiri; Hesham Eissa; Frederick Yeo; Wassim Chemaitilly; Matthew J Ehrhardt; Johnnie Bass; Michael W Bishop; Kyla Shelton; Lu Lu; Sujuan Huang; Zhenghong Li; Eric Caron; Jennifer Lanctot; Carrie Howell; Timothy Folse; Vijaya Joshi; Daniel M Green; Daniel A Mulrooney; Gregory T Armstrong; Kevin R Krull; Tara M Brinkman; Raja B Khan; Deo K Srivastava; Melissa M Hudson; Yutaka Yasui; Leslie L Robison
Journal:  Lancet       Date:  2017-09-08       Impact factor: 79.321

  9 in total
  3 in total

Review 1.  Challenges and Opportunities for Childhood Cancer Drug Development.

Authors:  Peter J Houghton; Raushan T Kurmasheva
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

2.  Evaluation of Eribulin Combined with Irinotecan for Treatment of Pediatric Cancer Xenografts.

Authors:  Andrew J Robles; Raushan T Kurmasheva; Abhik Bandyopadhyay; Doris A Phelps; Stephen W Erickson; Zhao Lai; Dias Kurmashev; Yidong Chen; Malcom A Smith; Peter J Houghton
Journal:  Clin Cancer Res       Date:  2020-03-17       Impact factor: 12.531

3.  Developing New Agents for Treatment of Childhood Cancer: Challenges and Opportunities for Preclinical Testing.

Authors:  Samson Ghilu; Raushan T Kurmasheva; Peter J Houghton
Journal:  J Clin Med       Date:  2021-04-04       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.